Tumor-associated fibroblasts promote the proliferation and decrease the doxorubicin sensitivity of liposarcoma cells.

about

Tumor-associated fibroblasts promote the proliferation and decrease the doxorubicin sensitivity of liposarcoma cells.

Item

http://www.wikidata.org/entity/Q36903707

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Tumor-associated fibroblasts p ...... sitivity of liposarcoma cells.

@en

type

Item

label

Tumor-associated fibroblasts p ...... sitivity of liposarcoma cells.

@en

prefLabel

Tumor-associated fibroblasts p ...... sitivity of liposarcoma cells.

@en

P1476

Tumor-associated fibroblasts p ...... nsitivity of liposarcoma cells

@en

P2093

Björn Behr

http://www.w3.org/2001/XMLSchema#string

Christoph Wallner

http://www.w3.org/2001/XMLSchema#string

Frank Jacobsen

http://www.w3.org/2001/XMLSchema#string

Kamran Harati

http://www.w3.org/2001/XMLSchema#string

Marcus Lehnhardt

http://www.w3.org/2001/XMLSchema#string

Mustafa Becerikli

http://www.w3.org/2001/XMLSchema#string

Tobias Hirsch

http://www.w3.org/2001/XMLSchema#string

P2860

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

Fibroblasts in cancer

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial.

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Staging and prognostic factors in soft tissue sarcoma.

Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts

Myxoid liposarcoma--the frequency and the natural history of nonpulmonary soft tissue metastases.

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

Differential sensitivity of liposarcoma subtypes to chemotherapy.

P304

1535-1541

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/IJMM.2016.2556

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Adrien Daigeler

P577

2016-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27082154

http://www.w3.org/2001/XMLSchema#string

P932

4867885

http://www.w3.org/2001/XMLSchema#string